Thank you for your support for DPC2018 – our most successful Event yet!
I’m delighted to see how much Diabetes Professional Care (DPC) has grown since its launch in 2015. We attracted a record-breaking 4,195 delegates to DPC2018, and I believe that remaining true to DPC’s original goals and commitments has been instrumental in the show’s continued growth and popularity.
Diabetes is still spiralling out of control, and patients are still not receiving enough education and support to understand and manage their condition and reduce the risk of developing serious complications. There’s an urgent need to raise awareness of these potentially life-threatening conditions among HCPs and patients in order to address the issue head-on.
DPC2018 featured a dedicated Diabetes Co-morbidities conference stream, which focused on mental health and wellbeing, cardiovascular disease, renal and diabetic kidney disease, and diabetic retinopathy. In addition to this, the DPC Foot & Wound Clinic, which we launched last year, made a welcome return. The Foot & Wound Clinic featured sessions on the practical skills and knowledge needed to prevent, treat and manage lower limb complications among people with diabetes. I sincerely hope this feature, with its real-world education for HCP’s, will make a difference to the lives of people with diabetes by reducing the number of avoidable amputations, which sadly continues to rise.
Like most people in this sector, I am alarmed at the increase of obesity and type 2 diabetes, particularly among younger people. This year’s Live Debate on ‘Preventing childhood obesity: whose responsibility?’ brought together four leading healthcare professionals and policymakers, who discussed the issue of childhood obesity from four different angles: policy, healthcare professionals, family, and technology.
On World Diabetes Day, we were able to give DPC delegates an exclusive first look at outcomes data from the DECLARE study on the impact of SGLT2 on type 2 diabetes patients with high CV risk. This ground-breaking research provides compelling evidence that Dapagliflozin has a positive effect on CV outcomes in patients with type 2 diabetes.
I set out to deliver a free-to-attend event that would ultimately improve the care and outcomes for people with diabetes. We are dedicated to providing HCPs across the whole MDT with the skills and knowledge needed to empower patients to take control of their care. We encourage you to invite colleagues to next year’s DPC event on 29 & 30 October next year, so they too can benefit from education, research and knowledge.
Together, we can prevent the rise of type 2 diabetes and achieve better outcomes for all patients living with diabetes. There is still much work to be done, but we are well on our way. So, thank you to our visitors, exhibitors, sponsors, and speakers for your support.
We would like to wish you and your colleagues a very Merry Christmas and a Happy New Year, and look forward to seeing you at DPC on 29th and 30th October 2019.
Founder, Diabetes Professional Care